DrugsControl Media Services

News Detail

Wockhardt announces success of antibiotic to treat drug-resistant infection (12-03-2024)

Mumbai, 12 March 2024: Wockhardt, a global pharmaceutical and biotech company, on Monday announced the successful use of an investigational antibiotic under-trial drug, Zidebactam/Cefepime, to treat a highly drug-resistant skull bone infection and pneumonia in a renal transplant ......
View Details

Source : Business Standard
Wockhardt news drug tested health care Pharma sector drugs human infection studies

Related News